Zhou X - Search Results

1

MiR-34a suppresses the proliferation and invasion of gastric cancer by modulating PDL1 in the immune microenvironment.

Yong H, Fu J, Gao G, Shi H, Zheng D, Zhou X. Yong H, et al. Among authors: zhou x. Mol Cell Probes. 2020 Oct;53:101601. doi: 10.1016/j.mcp.2020.101601. Epub 2020 May 20. Mol Cell Probes. 2020. PMID: 32445780

2

Chemotherapy regimen based on sorafenib combined with 5-FU on HIF-1α and VEGF expression and survival in advanced gastric cancer patients.

Cheng R, Yong H, Xia Y, Xie Q, Gao G, Zhou X. Cheng R, et al. Among authors: zhou x. Oncol Lett. 2017 Apr;13(4):2703-2707. doi: 10.3892/ol.2017.5769. Epub 2017 Feb 23. Oncol Lett. 2017. PMID: 28454454 Free PMC article.

3

CD155 expression and its prognostic value in postoperative patients with breast cancer.

Yong H, Cheng R, Li X, Gao G, Jiang X, Cheng H, Zhou X, Zhao W. Yong H, et al. Among authors: zhou x. Biomed Pharmacother. 2019 Jul;115:108884. doi: 10.1016/j.biopha.2019.108884. Epub 2019 Apr 28. Biomed Pharmacother. 2019. PMID: 31035013 Free article.

4

RNA-Binding Motif 4 (RBM4) Suppresses Tumor Growth and Metastasis in Human Gastric Cancer.

Yong H, Zhao W, Zhou X, Liu Z, Tang Q, Shi H, Cheng R, Zhang X, Qiu Z, Zhu J, Feng Z. Yong H, et al. Among authors: zhou x. Med Sci Monit. 2019 May 30;25:4025-4034. doi: 10.12659/MSM.914513. Med Sci Monit. 2019. PMID: 31145716 Free PMC article.

5

Naringin inhibits colorectal cancer cell growth by repressing the PI3K/AKT/mTOR signaling pathway.

Cheng H, Jiang X, Zhang Q, Ma J, Cheng R, Yong H, Shi H, Zhou X, Ge L, Gao G. Cheng H, et al. Among authors: zhou x. Exp Ther Med. 2020 Jun;19(6):3798-3804. doi: 10.3892/etm.2020.8649. Epub 2020 Apr 7. Exp Ther Med. 2020. PMID: 32346444 Free PMC article.

6

miR-504 Promoted Gastric Cancer Cell Proliferation and Inhibited Cell Apoptosis by Targeting RBM4.

Zhang Y, Yong H, Fu J, Gao G, Shi H, Zhou X, Fu M. Zhang Y, et al. Among authors: zhou x. J Immunol Res. 2021 Jun 4;2021:5555950. doi: 10.1155/2021/5555950. eCollection 2021. J Immunol Res. 2021. PMID: 34195294 Free PMC article.

7

TEAD4 Activates PCSK9 to Promote Stomach Adenocarcinoma Cell Stemness through Fatty Acid Metabolism.

Xu D, Han G, Zhou X, Yong H, Jia Y, Zhao F, Shi H. Xu D, et al. Among authors: zhou x. Digestion. 2024;105(4):243-256. doi: 10.1159/000538329. Epub 2024 Apr 26. Digestion. 2024. PMID: 38663369

8

Trop2 is a potential biomarker for the promotion of EMT in human breast cancer.

Zhao W, Kuai X, Zhou X, Jia L, Wang J, Yang X, Tian Z, Wang X, Lv Q, Wang B, Zhao Y, Huang W. Zhao W, et al. Among authors: zhou x. Oncol Rep. 2018 Aug;40(2):759-766. doi: 10.3892/or.2018.6496. Epub 2018 Jun 14. Oncol Rep. 2018. PMID: 29901160

9

Dose responsive effects of cisplatin in L02 cells using NMR-based metabolomics.

Liu S, Wang W, Zhou X, Gu R, Ding Z. Liu S, et al. Among authors: zhou x. Environ Toxicol Pharmacol. 2014 Jan;37(1):150-7. doi: 10.1016/j.etap.2013.11.016. Epub 2013 Nov 25. Environ Toxicol Pharmacol. 2014. PMID: 24322623

10

A 2-DE-based proteomic study on the toxicological effects of cisplatin in L02 cells.

Liu S, Wang W, Zhou X, Ding Z, Gu R. Liu S, et al. Among authors: zhou x. Environ Toxicol Pharmacol. 2015 Jan;39(1):167-75. doi: 10.1016/j.etap.2014.11.018. Epub 2014 Dec 5. Environ Toxicol Pharmacol. 2015. PMID: 25528407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,208 results

Search Page

Filters